Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis

Journal of Neuroinflammation

Volumn 12, Issue 1, 2015, Pages

  Owens, Geoffrey C ^a   Erickson, Kate L ^a   Malone, Colin C ^a   Pan, Calvin ^a   Huynh, My N ^a   Chang, Julia W ^a   Chirwa, Thabiso ^a   Vinters, Harry V ^a   Mathern, Gary W ^a,b   Kruse, Carol A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Brain; CDR3; Focal cortical dysplasia; Gamma delta T cells; Inflammation; Rasmussen encephalitis; T cell receptor; T cells

Indexed keywords

CD69 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; COMPLEMENTARITY DETERMINING REGION; LECTIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ALPHA BETA T LYMPHOCYTE; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CORTICAL DYSPLASIA; CYTOKINE RELEASE; DNA SEQUENCE; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; RASMUSSEN SYNDROME; SCHOOL CHILD; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; BRAIN; COHORT ANALYSIS; COMPARATIVE STUDY; ENCEPHALITIS; EPILEPSY; IMMUNOLOGY; INFANT; MALFORMATION OF CORTICAL DEVELOPMENT GROUP I; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BRAIN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMPLEMENTARITY DETERMINING REGIONS; ENCEPHALITIS; EPILEPSY; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFANT; LECTINS, C-TYPE; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP I; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 84937542605     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0352-2     Document Type: Article

References (58)

1. Rasmussen T, Olszewski J, Lloydsmith D. Focal seizures due to chronic localized encephalitis. Neurology. 1958;8:435-45.
2. Bien CG, Tiemeier H, Sassen R, Kuczaty S, Urbach H, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia. 2013;54:543-50.
3. Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, et al. Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014;13:195-205.
4. Walter GF, Renella RR. Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet. 1989;1:279-80.
5. Power C, Poland SD, Blume WT, Girvin JP, Rice GP. Cytomegalovirus and Rasmussen's encephalitis. Lancet. 1990;336:1282-4.
6. Vinters HV, Wang R, Wiley CA. Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Hum Pathol. 1993;24:871-9.
7. Atkins MR, Terrell W, Hulette CM. Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol. 1995;14:7-12.
8. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science. 1994;265:648-51.
9. Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology. 2001;57:1511-4.
10. Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology. 2004;63:43-50.
11. Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol. 2002;131:179-85.
12. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol. 2002;51:311-8.
13. Dechanet J, Merville P, Lim A, Retiere C, Pitard V, et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest. 1999;103:1437-49.
14. Alamyar E, Duroux P, Lefranc MP, Giudicelli V. IMGT((R)) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. Methods Mol Biol. 2012;882:569-604.
15. Gouy M, Guindon S, Gascuel O. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol. 2010;27:221-4.
16. Prayson RA, Frater JL. Rasmussen encephalitis: a clinicopathologic and immunohistochemical study of seven patients. Am J Clin Pathol. 2002;117:776-82.
17. Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, et al. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia. 2004;45:516-26.
18. Owens GC, Huynh MN, Chang JW, McArthur DL, Hickey MJ, et al. Differential expression of interferon-gamma and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Neuroinflammation. 2013;10:56.
19. Born WK, Kemal Aydintug M, O'Brien RL. Diversity of gammadelta T-cell antigens. Cell Mol Immunol. 2013;10:13-20.
20. Hayday AC. [Gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000;18:975-1026.
21. Pang DJ, Neves JF, Sumaria N, Pennington DJ. Understanding the complexity of gammadelta T-cell subsets in mouse and human. Immunology. 2012;136:283-90.
22. Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52:158-74.
23. Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia. 2010;51:1763-73.
24. Hayday AC. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity. 2009;31:184-96.
25. Kabelitz D, Peters C, Wesch D, Oberg HH. Regulatory functions of gammadelta T cells. Int Immunopharmacol. 2013;16:382-7.
26. Girardi M. Immunosurveillance and immunoregulation by gammadelta T cells. J Invest Dermatol. 2006;126:25-31.
27. Kalyan S, Kabelitz D. Defining the nature of human gammadelta T cells: a biographical sketch of the highly empathetic. Cell Mol Immunol. 2013;10:21-9.
28. Chien YH, Meyer C, Bonneville M. gammadelta T cells: first line of defense and beyond. Annu Rev Immunol. 2014;32:121-55.
29. Ribot JC, debarros A, Silva-Santos B. Searching for "signal 2": costimulation requirements of gammadelta T cells. Cell Mol Life Sci. 2011;68:2345-55.
30. Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain. 2009;132:1236-46.
31. Li Y, Uccelli A, Laxer KD, Jeong MC, Vinters HV, et al. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol. 1997;158:1428-37.
32. Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med. 2010;207:807-21.
33. Venturi V, Price DA, Douek DC, Davenport MP. The molecular basis for public T-cell responses? Nat Rev Immunol. 2008;8:231-8.
34. Luoma AM, Castro CD, Mayassi T, Bembinster LA, Bai L, et al. Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T cells. Immunity. 2013;39:1032-42.
35. Uldrich AP, Le Nours J, Pellicci DG, Gherardin NA, McPherson KG, et al. CD1d-lipid antigen recognition by the gammadelta TCR. Nat Immunol. 2013;14:1137-45.
36. Xu B, Pizarro JC, Holmes MA, McBeth C, Groh V, et al. Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA. Proc Natl Acad Sci U S A. 2011;108:2414-9.
37. Yacubian EM, Rosemberg S, Marie SK, Valerio RM, Jorge CL, et al. Double pathology in Rasmussen's encephalitis: etiologic considerations. Epilepsia. 1996;37:495-500.
38. Hart YM, Andermann F, Robitaille Y, Laxer KD, Rasmussen T, et al. Double pathology in Rasmussen's syndrome: a window on the etiology? Neurology. 1998;50:731-5.
39. Palmer CA, Geyer JD, Keating JM, Gilliam F, Kuzniecky RI, et al. Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3. Epilepsia. 1999;40:242-7.
40. Takei H, Wilfong A, Malphrus A, Yoshor D, Hunter JV, et al. Dual pathology in Rasmussen's encephalitis: a study of seven cases and review of the literature. Neuropathology. 2010;30:381-91.
41. Prayson RA. Dual pathology in Rasmussen's encephalitis: a report of coexistent focal cortical dysplasia and review of the literature. Case Rep Pathol. 2012;2012:569170.
42. O'Rourke DJ, Bergin A, Rotenberg A, Peters J, Gorman M, et al. Rasmussen's encephalitis presenting as focal cortical dysplasia. Epilepsy Behav Case Rep. 2014;2:86-9.
43. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol. 2013;244:11-21.
44. Keyel PA. How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. Cytokine. 2014;69:136-45.
45. Ramaswamy V, Walsh JG, Sinclair DB, Johnson E, Tang-Wai R, et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis. J Neuroinflammation. 2013;10:152.
46. Sutton CE, Mielke LA, Mills KH. IL-17-producing gammadelta T cells and innate lymphoid cells. Eur J Immunol. 2012;42:2221-31.
47. Blink SE, Miller SD. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Curr Mol Med. 2009;9:15-22.
48. Cai Y, Fleming C, Yan J. Dermal gammadelta T cells-a new player in the pathogenesis of psoriasis. Int Immunopharmacol. 2013;16:388-91.
49. Prinz I, Silva-Santos B, Pennington DJ. Functional development of gammadelta T cells. Eur J Immunol. 2013;43:1988-94.
50. Ribot JC, Silva-Santos B. Differentiation and activation of gammadelta T Lymphocytes: focus on CD27 and CD28 costimulatory receptors. Adv Exp Med Biol. 2013;785:95-105.
51. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41-101.
52. Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science. 1995;269:549-52.
53. Pardo CA, Nabbout R, Galanopoulou AS. Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES). Neurotherapeutics. 2014;11:297-310.
54. McLachlan RS, Levin S, Blume WT. Treatment of Rasmussen's syndrome with ganciclovir. Neurology. 1996;47:925-8.
55. Powell AM, Black MM. Epitope spreading: protection from pathogens, but propagation of autoimmunity? Clin Exp Dermatol. 2001;26:427-33.
56. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002;2:85-95.
57. Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol Rev. 2012;245:227-38.
58. Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012;42:102-11.